about
Evasion of the Immune Response by Trypanosoma cruzi during Acute InfectionMechanisms of Trypanosoma cruzi persistence in Chagas diseaseEffects of astaxanthin in mice acutely infected with Trypanosoma cruziTrypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes.The role of haptoglobin genotypes in Chagas disease.Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis.Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major.Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Functional characterization of 8-oxoguanine DNA glycosylase of Trypanosoma cruzi.Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.Trypanosoma cruzi infection induces a global host cell response in cardiomyocytesNonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi InfectionTherapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-ExpressionChanges in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas DiseaseConcomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruziSIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease.Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant responseCurcumin treatment provides protection against Trypanosoma cruzi infectionCurcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.Chemotherapeutic efficacy of phosphodiesterase inhibitors in chagasic cardiomyopathy.Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.Melatonin: Antioxidant and modulatory properties in age-related changes during Trypanosoma cruzi infection.Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection.Evaluation of antioxidant therapy in experimental Chagas disease.Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease.Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.EFFECTS OF VITAMIN C SUPPLEMENTATION ON THE CHRONIC PHASE OF CHAGAS DISEASE.Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease.Discovery of Candidate Biomarkers.Purinergic Antagonist Suramin Aggravates Myocarditis and Increases Mortality by Enhancing Parasitism, Inflammation, and Reactive Tissue Damage in -Infected MiceDiet Modulates Adipose Tissue Oxidative Stress in a Murine Acute Chagas Model
P2860
Q26772721-76FD1CB3-9102-46DD-AA72-B9929ED20A57Q26858780-15DD8545-2E5C-4E3F-8B14-5BE8B858658FQ30096798-4C88ED1B-5179-4C6C-B23C-EC9FA138508FQ33799832-256A2C4B-9EF2-4F35-B962-8D95F79FFC9CQ34053016-6B647581-D0DA-4957-9B84-B6974A6FB64FQ34112124-6AA6EA91-5463-4239-9245-56FDE92E224BQ34124960-BB78F419-BD36-4904-B1A4-9B7007784C74Q34189677-1D365FC2-0870-437F-8AF0-6282608006DFQ34250328-2D0D8AD4-8317-4E8E-9811-179C5CA0B7C6Q34372632-4BF918FE-F183-4F19-B08E-91249F8A0159Q34603215-6BFC17F1-F430-446B-A7E9-6D639E3E3EC4Q34931802-7D37A698-836B-4B9C-9A66-D86ED7ADE10FQ35173250-3D84C843-DC72-4AB3-AB30-5974DCECE73CQ35663668-F79CFEE6-3D91-42C1-B919-44B9AF44AE9FQ35937562-E319B324-E208-4EF9-BEF9-48C84F87BC60Q36075925-2B0E6DBF-BBEC-4007-BB1D-AF7C0A767DDEQ36169626-E22AAABD-7039-48B7-8C30-1840CF2B7BA2Q36519814-BF2006F6-66D6-4AFA-85DF-9A8E8E190773Q36566715-EAE3F68E-8607-4D56-888F-03317800194DQ36933422-05A9C442-8A81-4A24-928C-F4BDA5F72464Q37341337-32067AAA-D921-4346-860B-CA1FB0C368CFQ37713220-E166E950-4474-458F-ACFF-C5DB53DA89F7Q38859563-E48B26A2-3E47-4234-A9C7-46276258A569Q39185798-9F98C59A-6AC0-4539-B0BA-3C8A4CF59455Q40190859-F21AFF14-531B-4E93-B03D-DF942E75B26FQ40354504-EC5D96C9-02AC-4792-B82D-DC19F92E2A56Q40849132-A5D184A5-99E7-4B90-A37F-1DED00D26469Q41095664-DE2FABE5-DB1E-4A47-90F8-7EED9ADBAA16Q42135513-219ED12B-0970-41FA-9918-02DB05014040Q50533595-8280A2FA-8956-463E-9D85-D116310AE11EQ58604358-61E66088-A0CC-435D-8EBA-B4A486CBBD8FQ58842383-6F5FB422-67DD-4BE6-A1EF-1F377E471C7E
P2860
description
scientific article published on 14 June 2009
@en
наукова стаття, опублікована у 2009
@uk
type
P2860
P356
P2093
Nisha Jain Garg
Shivali Gupta
P2860
P304
P356
10.1155/2009/190354
P407
P50
P577
2009-06-14T00:00:00Z